Ji Sook MOON,Chul KIM,Ji Min PARK,Sang Hun BAE,Hyun Sook KIM,Joopyung KIM,Ok Joon KIM
申请号：
US15523160
公开号：
US20180280447A1
申请日:
2015.10.29
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to placenta-derived cells excreting C3 or C1R complement proteins, a pharmaceutical composition containing same, and a method for treating diseases using the placenta-derived cells. The placenta-derived cells, according to the present invention, can be effectively applied to Alzheimers disease, Parkinsons disease, HIV, neurodegenerative diseases such as dementia and epilepsy, or angiogenesis-related diseases such as cancer and retinopathy, thereby having high industrial utility.
